Corporate News Report on Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS)

The Shanghai Stock Exchange witnessed a quiet trading day for Henan Lingrui Pharmaceutical (600285.SS) on Friday, 23 November 2026. The share price remained unchanged, moving flat at 0 % over the 24‑hour period that concluded at 22:38 Central Europe time. At the close, the stock traded at CNH 20.32, a modest decline from the previous closing level of CNH 20.60.

Market Position and Recent Performance

Henan Lingrui has maintained a steady upward trajectory since the end of the previous month, recording a 7.55 % increase in its trading activity. With a current market capitalisation of approximately CNH 1.60 bn, the company commands a modest yet significant presence in the Chinese pharmaceutical sector. The total supply of its shares outstanding is 567.1 million, and in the last 24 hours, roughly CNH 232.3 million worth of Henan Lingrui shares changed hands, underscoring active investor interest despite the flat price movement.

The 200‑day simple moving average sits at CNH 20.74, placing the current price slightly below this long‑term benchmark. Over the past year, the share’s performance has been marked by volatility: the 52‑week high of CNH 23.65 was reached on 3 August 2026, while the 52‑week low of CNH 18.51 occurred on 28 September 2026. These extremes illustrate the stock’s capacity for both growth and retracement, a characteristic that investors will watch closely as the company continues to expand its product lines in ointments, electuaries, tablets, and capsules.

The broader market context reveals a similar pattern of stability among peer companies in the region:

  • Shanghai Flyco Electrical (603868.SS) – Unchanged at 0 % and trading at CNH 32.23, with a market capitalisation of CNH 1.9 bn and a price‑earnings ratio of 25.5.
  • Yunnan Jinxun‑H (3636.HK) – Flat at 0 % and priced at HKD 5.73, its market capitalisation stands at HKD 2.1 bn, and the company’s price‑to‑earnings ratio is 4.18.
  • Jiangsu Jingyuan Environmental Protection (688096.SS) – Also flat at 0 % and trading at CNY 6.94, with a market capitalisation of CNY 1.8 bn.
  • Ehang (EH) – Slightly down by –0.7 % and currently at USD 3.39, the company has a market capitalisation of USD 267.7 mn.
  • Haxc (300928.SZ) – Unchanged at 0 % and priced at CNY 21.9, holding a market capitalisation of CNY 1.8 bn.

These figures suggest a broader market tendency toward consolidation rather than pronounced movement, positioning Henan Lingrui’s flat day as part of a larger pattern of equilibrium among Chinese industrial and pharmaceutical equities.

Company Overview

Henan Lingrui Pharmaceutical Co., Ltd., incorporated in Henan province, specializes in the production and marketing of traditional Chinese medicines. Its product portfolio includes ointments, electuaries, tablets, and capsules, catering to both domestic and international markets. The company debuted on the Shanghai Stock Exchange on 14 September 2000, and since then it has steadily built a reputation for quality and innovation within the Chinese medicinal sector.

Investors interested in the company can visit the official website at www.lingrui.com for the latest corporate disclosures, product updates, and market commentary.